In a groundbreaking move set to reshape the investment management software landscape, Clearwater Analytics announced on Monday that it will acquire Enfusion, a leader in software solutions for the hedge fund and investment management sectors, for a staggering $1.5 billion.
A $1.5 Billion Merger: Cash and Stock for Enfusion’s Future
Under the terms of the acquisition, Clearwater will purchase Enfusion for $11.25 per share. The deal is structured as a combination of cash and stock, with $5.85 per share being paid in cash and $5.40 per share in Clearwater Class A common stock. In total, Clearwater will pay approximately $760 million in cash and issue between 23 million and 28 million new shares to Enfusion’s shareholders.
This monumental transaction, which brings together two industry giants in cloud-native investment management technology, is expected to create a unified platform designed to enhance services for institutional investors worldwide.
Powerhouse Legal Teams Behind the Deal
The deal is the result of efforts by three prestigious law firms. Clearwater has been advised by Kirkland & Ellis LLP, while Enfusion has been represented by Goodwin Procter LLP. Enfusion’s special committee also received counsel from Dechert LLP.
